Research Associate

Responsibilities

• Execute LC, CE, and other physicochemical testing to support CMC program activities
• Develop and qualify LC, CE, and other physicochemical analytical methods
• Author and review test methods, qualification protocols, and technical reports
• Present experimental designs and results at AS, internal cross-functional, and external meetings
• Support external test lab documentation and data review
• Support lab management activities including equipment maintenance scheduling, testing calendar scheduling, inventory management, shipping and receiving, and waste disposal
• Ensure test methods development and execution activities are conducted in accordance with applicable regulatory requirements, internal policies, scientific standards, and project timelines

Requirements

• Science related Bachelor degree, or MS degree with 2+ years of laboratory experience; pharmaceutical or biotechnology industry experience preferred
• Hands-on experience with HPLC/UPLC (CEX, RP, SEC), CE (icIEF, CE-SDS), and other spectroscopic method used for protein therapeutic testing
• Knowledge of cGMP requirements, ICH guidelines, regulatory expectations, and data integrity requirements preferred
• Proficiency with MS Office, Word, PowerPoint, and Excel software is required
• Experience with laboratory notebooks is required
• Data Sciences and statistical experience with software packages such as Minitab or JMP is preferred

Qualifications

• Demonstrated ability to build and maintain positive, collaborative relationships with management, peers, subordinates, cross-functional teams, and external contract organizations
• Strong scientific judgment and ability to make sound technical decisions in relevant situations
• Excellent written and oral communication skills, with the ability to clearly communicate complex scientific concepts to technical and non-technical audiences
• Strong organizational, problem-solving, and decision-making skills with the ability to manage multiple priorities in a fast-paced environment
• Self-motivated and detail-oriented, with the highest integrity and commitment to quality, compliance, and scientific excellence

Benefits

Omeros is proud to offer a competitive total compensation package designed to support the lives of our employees and their families. The wage scale for this position is ($65,000 – $85,000). Salaries will be determined based on knowledge, skills, education, and experience relevant to the role. Employees are offered medical, dental, vision, life insurance, and a 401(k) plan with a company match. Employees accrue three weeks of vacation and 80 hours of sick time on an annual basis and receive twelve paid holidays throughout the calendar year. This position is eligible for incentive and stock options.

About the Role

Who is Omeros? Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector enzyme MASP-2, is FDA-approved and commercially available in the U.S. for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients aged two years and older. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials. Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), an inhibitor of MASP-3, the alternative pathway’s key activator, which is in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder, which is fully funded by the National Institute on Drug Abuse, and a growing portfolio of novel recombinant antibodies targeting multidrug-resistant organisms and novel molecular and cellular therapeutic programs for oncology. For more information about Omeros and its programs, visit www.omeros.com.